Glenmark Pharma spurts on receiving ANDA approvals for migraine headaches tablets

15 May 2013 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs 560.85, up by 13.20 points or 2.41% from its previous closing of Rs 547.65 on the BSE.

The scrip opened at Rs 555.00 and has touched a high and low of Rs 563.45 and Rs 551.05 respectively. So far 32876 shares were traded on the counter.

The BSE group 'A' stock of face value Re 1 has touched a 52 week high of Rs 556.80 on 10-May-2013 and a 52 week low of Rs 332.25 on 18-May-2012.

Last one week high and low of the scrip stood at Rs 556.80 and Rs 520.15 respectively. The current market cap of the company is Rs 15228.44 crore.

The promoters holding in the company stood at 48.31% while Institutions and Non-Institutions held 40.52% and 11.18% respectively.

Glenmark Generics Inc, USA, a subsidiary of Glenmark Pharmaceuticals has been granted final abbreviated new drug approvals (ANDA’s) from the United States Food and Drug Administration (USFDA) for Zolmitriptan Tablets, 2.5 and 5mg and Zolmitriptan Orally Disintegrating Tablets, 2.5 and 5mg. The pharma major will commence distribution of the product immediately.

Zolmitriptan Tablets and Zolmitriptan ODT are Glenmark’s generic versions of Zomig and Zomig ZMT by AstraZeneca, indicated for the acute treatment of migraine headaches in adults. According to IMS Health for the 12 month period ending December 2012, the products garnered annual sales of $176 million.

Glenmark’s current portfolio consists of 85 products authorized for distribution in the US marketplace and 50 ANDA’s pending approval with the USFDA. In addition to these internal filings, GGI continues to identify and explore external development partnerships to supplement and accelerate the growth of the existing pipeline and portfolio.

Glenmark Pharma Share Price

1974.05 17.65 (0.90%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×